AJOVista’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,794
Closed -$42.4K 453
2023
Q4
$42.4K Buy
+1,794
New +$31.9K 0.05% 308

Other funds holding CBAY

AJOVista's CBAY Position: Q1 2024 in Review

AJOVista sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 1,794 shares — an estimated $42.4K sold.

AJOVista first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $42.4K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • AJOVista reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • AJOVista sold 1,794 Cymabay Therapeutics shares in Q1 2024, an estimated $42.4K.
  • AJOVista first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
  • AJOVista's Cymabay Therapeutics position peaked at $42.4K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.